Life Sciences & Chemicals

The changed economic, social and geopolitical situation, characterised by political tensions and armed conflicts, has led the life sciences and chemical industries into a new, more volatile era. Companies in both sectors are undergoing a process of transformation. They are required to become much more agile, digital and networked in their respective ecosystems. The change and individualisation of customer needs remains one of the biggest challenges. However, life sciences and chemical companies are also focusing on topics such as digital transformation, stable supply chains and holistic sustainability. 

Digitalisation in the life sciences industry primarily concerns the areas of digitalisation in research and development as well as production, patient and doctor interactions and digital therapies. Collaboration with start-ups and technology companies can make a big difference here. In addition, life sciences companies need to improve their ESG balance sheet by steadily expanding their social contribution to even broader and affordable healthcare in addition to decarbonisation. 

The German chemical industry continues to face serious challenges, such as in the area of supply chains in Asia and China. However, companies are also under pressure from sharply rising raw material prices, their availability, the stability of the energy supply and increased sustainability requirements. The development of resilient supply networks, the adaptation of the energy mix and further digitalisation will play a decisive role in the future.

Our experts will help you to better position your company for the future and support you in the transformation to a more customer-oriented and competitive company.